Rebalix
Logo AmundiAmundi · sheet of 5 September 2026
ETF sheet · official issuer and register data

Amundi Core S&P 500 UCITS ETF Acc

CSP5 · IE000UBAW7M3 · class UCITS ETF Acc · USD · domicile Ireland
Equity · United States · Large capSFDR art. 6
Index tracked: S&P 500 Net Total Return Index
TER
0.03%+ trans. 0.01%
Fund size
21 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 10 Apr 2025 · costs from the KID as of 2 Sept 2026 · 504 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 21 Aug 2026
The Sub-Fund is passively managed. The objective of the Sub-Fund is to track the performance of the index “S&P 500 Index” (the “Index”). The anticipated level of tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund The Index is an equity index and a free-float capitalization-weighted index, representative of the performance of the 500 leading U.S. companies listed in the United States. To be included, the companies must be domiciled in the United Stated, have an unadjusted market cap of USD 18.0 billion or…

Performance since series start (in euro) — base 100

14 Apr 20253 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202614497142
High 144 (13 Aug 2026) · low 97 (22 Apr 2025) · last 142. Past performance is not indicative of future results.

Returns in euro

1 year+22.2%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+42.3%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.74%12.74%
Max drawdown−8.95%−8.95%
Sharpe1.391.39
Sortino2.022.02
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CSP5 · IE000UBAW7M31
RebalixCSP5 · IE000UBAW7M3 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 504 securities · top-10 weight = 37.8%
Top holdingsWeight
NVIDIA CORP8.0%
APPLE INC7.3%
MICROSOFT CORP5.7%
AMAZON.COM INC3.8%
ALPHABET INC CL A3.0%
BROADCOM INC2.7%
ALPHABET INC CL C2.4%
META PLATFORMS INC-CLASS A1.9%
MICRON TECHNOLOGY INC1.6%
TESLA INC1.5%
Countries (% of fund)
United States100.0%
Sectors (% of fund)
Information Technology37.8%Financials12.3%Communication Services9.5%Health Care9.4%Consumer Discretionary9.0%

Listing venues

ESMA register (FIRDS) and official exchange lists
· Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
CSP6 · Xetra (Deutsche Börse)
+ 11 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/IE000UBAW7M3/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/IE000UBAW7M3/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/IE000UBAW7M3/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/IE000UBAW7M3
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · CSP5 · IE000UBAW7M32